Tocilizumab - Wikipedia

Tocilizumab, also known as atlizumab, is an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis ...

Tocilizumab – Wikipedia

Klinische Angaben Anwendungsgebiete Rheumatoide Arthritis. Tocilizumab ist, in Kombination mit Methotrexat (MTX), für die Behandlung erwachsener Patienten mit ...

RA, GCA, SJIA, PJIA Treatment | ACTEMRA® (tocilizumab)

Learn about ACTEMRA® treatment for rheumatoid arthritis, giant cell arteritis, systemic juvenile idiopathic arthritis, and polyarticular juvenile idiopathic arthritis.

Tocilizumab - Informazioni sui farmaci

Tocilizumab è un nuovo farmaco biologico per uso endovenoso che inibisce la citochina pro-infiammatoria interleukina-6. Associato al metotrexato si è dimostrato ...

Trial of Tocilizumab in Giant-Cell Arteritis | NEJM

BackgroundGiant-cell arteritis commonly relapses when glucocorticoids are tapered, and the prolonged use of glucocorticoids is associated with side effects. The ...

Tocilizumab monotherapy versus adalimumab monotherapy for ...

Background. Roughly a third of patients with rheumatoid arthritis treated with biological treatments receive them as monotherapy. Tocilizumab—an inhibitor of ...

RoActemra 20mg/ml Concentrate for Solution for Infusion ...

RoActemra 20mg/ml Concentrate for Solution for Infusion - Summary of Product Characteristics (SmPC) by Roche Products Limited

LusiNEX (tocilizumab) | 永昕生物醫藥

LusiNEX為生物相似藥(原廠生物藥：Actemra®/ RoActemra®)，能與第六介白素受體(IL-6R)結合，藉以阻斷IL-6的作用，達到抗發炎與調節 ...

RoACTEMRA (Tocilizumab) - Home

RoACTEMRA.de: Informationen zur Therapie der Rheumatoiden Arthritis für Ärzte und Apotheker

RoActemra 162 mg solution for injection in pre-filled pen ...

Each pre-filled pen contains 162 mg of RoActemra (tocilizumab) in 0.9 mL. RoActemra is a recombinant humanized, anti-human monoclonal antibody of the immunoglobulin ...